Kufareva, Irina http://orcid.org/0000-0001-9083-7039
Bestgen, Benoit
Brear, Paul
Prudent, Renaud
Laudet, Béatrice
Moucadel, Virginie
Ettaoussi, Mohamed
Sautel, Celine F.
Krimm, Isabelle
Engel, Matthias
Filhol, Odile http://orcid.org/0000-0003-1964-7958
Borgne, Marc Le http://orcid.org/0000-0003-1398-075X
Lomberget, Thierry
Cochet, Claude
Abagyan, Ruben
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM117424, GM074832)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI118985)
Région Auvergne-Rhône-Alpes (ARC 1 Santé 12-008707-01, ARC 1 Santé 12-008707-01, ARC 1 Santé 12-008707-01)
Institut National Du Cancer (2011-097, 2011-097, 2011-097, No 57)
Agence Nationale de la Recherche (PCV08_324733)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Article History
Received: 15 May 2019
Accepted: 7 October 2019
First Online: 4 November 2019
Competing interests
: R.A. has an equity interest in Molsoft, LLC. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.